Evotaz (atazanavir + cobicistat)

Evotaz (3641)


Evotaz is a single film-coated tablet that contains atazanavir (300 mg) plus the booster cobicistat (150 mg).

Evotaz was approved in the EU and the US in January 2015.

Evotaz is not routinely available yet in the UK.

See also: atazanavir and cobicistat.

Link to US prescribing information package insert.

Link to US pateint information leaflet. (PDF)